Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion type Assertion NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_head.
- NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion description "[Loss of TSLC1 expression was also observed in 20 of 46 (43%) human cancer cell lines, including those from esophageal (3 of 3), gastric (8 of 9), ovarian (2 of 5), endometrial (2 of 2), breast (1 of 3), colorectal (2 of 8) and small cell lung cancers (2 of 10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_provenance.
- NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion evidence source_evidence_literature NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_provenance.
- NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion SIO_000772 12925956 NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_provenance.
- NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion wasDerivedFrom befree-20150227 NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_provenance.
- NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_assertion wasGeneratedBy ECO_0000203 NP877200.RAX1HMp1LnWcmsrP8y8v7feTQROscvkDb_hpm542Mb8pY130_provenance.